Home » Topics » Regulatory » Patents

Patents
RSS

Bristol Myers Squibb patents CD80/PD-L1 and/or PD-1/PD-L1 interaction inhibitors

Aug. 3, 2021

Hovione Scientia describes ligand drug conjugates including BET inhibitors

Aug. 3, 2021

Jiangsu Simcere Pharmaceutical R&D discovers MAT2A inhibitors

Aug. 2, 2021

Beijing Kang Dini Pharmaceutical presents new IL-8 expression inhibitors

Aug. 2, 2021

DNA-dependent protein kinase inhibitors discovered at Chengdu Baiyu Pharmaceutical

Aug. 2, 2021

New glucocorticoid receptor modulators identified at Medshine Discovery

Aug. 2, 2021

BioWorld MedTech Patent Highlights: Week 29

From Current Patent Gazette

July 30, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Reyoung divulges new autophagy inhibitors

July 30, 2021

LegoChem Biosciences descibes new antibody-drug conjugates

July 30, 2021

New DNA-dependent protein kinase inhibitors identified at Chengdu Baiyu Pharmaceutical

July 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...